BRACAp
14 Sep 2023
BRACAp
NCT04711109
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
Alliance for Clinical Trials in Oncology
Cancer Type | Breast |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 25 to 55 years |
Sex | Female |
Tumour Stream | - |
Cancer Stage | - |
Anticipated Start Date | 2022-02-23 |
Anticipated End Date | 2033-12-01 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
Anne.Milton@sa.gv.au | |
Phone | 08 7074 2342 |
Principal Investigator | Eryn Dow |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs